409 related articles for article (PubMed ID: 27509979)
1. Tumor Necrosis Factor Alpha 308 G/A Single Nucleotide Polymorphism and Susceptibility to Hepatocellular Carcinoma Via Hepatitis B Infection.
Azar SS; Mansoori M; Attar M; Shahbazi M
Asian Pac J Cancer Prev; 2016; 17(7):3381-4. PubMed ID: 27509979
[TBL] [Abstract][Full Text] [Related]
2. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
[TBL] [Abstract][Full Text] [Related]
3. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
4. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6-174 Promoter Polymorphism and Susceptibility to Hepatitis B Virus Infection as a Risk Factor for Hepatocellular Carcinoma in Iran.
Attar M; Azar SS; Shahbazi M
Asian Pac J Cancer Prev; 2016; 17(5):2395-9. PubMed ID: 27268603
[TBL] [Abstract][Full Text] [Related]
6. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
[TBL] [Abstract][Full Text] [Related]
7. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
Cheong JY; Shin HD; Cho SW; Kim YJ
J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
[TBL] [Abstract][Full Text] [Related]
8. Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis.
Xiao Q; Fu B; Chen P; Liu ZZ; Wang W; Ye Q
Medicine (Baltimore); 2016 Dec; 95(50):e5609. PubMed ID: 27977601
[TBL] [Abstract][Full Text] [Related]
9. The relationship between TNF alpha gene polymorphisms (-238/-308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population.
Sghaier I; Zidi S; Mouelhi L; Dabbech R; Ghazouani E; Brochot E; Stayoussef M; Yacoubi-Loueslati B
Gene; 2015 Sep; 568(2):140-5. PubMed ID: 25982858
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
11. [Association between interleukin-18 gene polymorphisms and hepatocellular carcinoma caused by hepatitis B virus].
Zhang QX; Yao YQ; Li SL; Long Q
Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):352-7. PubMed ID: 27470888
[TBL] [Abstract][Full Text] [Related]
12. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
Zhang QX; Li SL; Yao YQ; Li TJ
Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
[TBL] [Abstract][Full Text] [Related]
13. SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B.
Hoan NX; Van Tong H; Giang DP; Cuong BK; Toan NL; Wedemeyer H; Bock CT; Kremsner PG; Song LH; Velavan TP
Oncotarget; 2017 Mar; 8(10):17127-17139. PubMed ID: 28179578
[TBL] [Abstract][Full Text] [Related]
14. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
15. The influence of caveolin-1 gene polymorphisms on hepatitis B virus-related hepatocellular carcinoma susceptibility in Chinese Han population: A case-control study.
Zhang J; Xue F; Chen S; Zhang D; Lu C; Tang G
Medicine (Baltimore); 2017 Oct; 96(42):e7359. PubMed ID: 29049173
[TBL] [Abstract][Full Text] [Related]
16. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
He Y; Zhang H; Yin J; Xie J; Tan X; Liu S; Zhang Q; Li C; Zhao J; Wang H; Cao G
Carcinogenesis; 2009 Nov; 30(11):1916-22. PubMed ID: 19797428
[TBL] [Abstract][Full Text] [Related]
17. TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits.
Li Z; Liu Z; Zhang G; Han Q; Li N; Zhu Q; Lv Y; Chen J; Xing F; Wang Y; Li F
Tissue Antigens; 2012 Aug; 80(2):151-7. PubMed ID: 22587604
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in complement receptor 1 gene and its association with HBV-related liver disease: A case-control study.
Luo J; Chen S; Wang J; Ou S; Zhang W; Liu Y; Qin Z; Xu J; Lu Q; Mo C; Li S; Qin X
Gene; 2019 Mar; 688():107-118. PubMed ID: 30529247
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 3 genetic variants and susceptibility to hepatocellular carcinoma and HBV-related hepatocellular carcinoma.
Li G; Zheng Z
Tumour Biol; 2013 Jun; 34(3):1589-94. PubMed ID: 23404408
[TBL] [Abstract][Full Text] [Related]
20. [Association of CTLA4 gene +49G/A polymorphism with HBV infection and HBV-related hepatocellular carcinoma in Hunan Han population].
Liu G; Lu GX
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1838-40. PubMed ID: 20813679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]